Failure of growth hormone-suppressing agents to affect TSH-releasing hormone- and LH-releasing hormone-induced growth hormone release in acromegaly
- PMID: 401823
- DOI: 10.1210/jcem-44-1-189
Failure of growth hormone-suppressing agents to affect TSH-releasing hormone- and LH-releasing hormone-induced growth hormone release in acromegaly
Abstract
In patients with acromegaly whose basal plasma GH levels were suppressed with 9 mg/day of dexamethasone for 2 days, TRH-(6 cases) and LHRH-(1 case) induced GH release were unaffected when the responses were compared to the basal levels. Phentolamine infusion, 70 mg in 150 min, or hyperglycemia induced by iv infusion of 700 ml of 50% glucose solution also did not suppress TRH-induced GH release in 2 acromegalic patients whose basal GH levels were lowered with these agents alone. These results seem to indicate that dexamethasone does not affect TRH- or LHRH-induced GH release per se, but affects the basal state which determines the absolute level of response. They also support the concept that TRH and LHRH act directly on pituitary tumor cells to release GH in acromegaly.
Similar articles
-
Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.J Endocrinol Invest. 1992 Mar;15(3):167-71. doi: 10.1007/BF03348697. J Endocrinol Invest. 1992. PMID: 1624675
-
Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.J Clin Endocrinol Metab. 1986 Jul;63(1):167-73. doi: 10.1210/jcem-63-1-167. J Clin Endocrinol Metab. 1986. PMID: 2872226
-
Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.Neuropeptides. 1993 Dec;25(6):363-75. doi: 10.1016/0143-4179(93)90056-g. Neuropeptides. 1993. PMID: 8127416
-
"Paradoxical" growth hormone secretion in acromegaly: an avian model?J Exp Zool Suppl. 1990;4:195-9. doi: 10.1002/jez.1402560442. J Exp Zool Suppl. 1990. PMID: 1974792 Review.
-
A critical review of the clinical relevance of growth hormone and its measurement in the nuclear medicine laboratory.Semin Nucl Med. 1975 Jul;5(3):273-85. doi: 10.1016/s0001-2998(75)80015-8. Semin Nucl Med. 1975. PMID: 807973 Review.
Cited by
-
Acromegaly with 'normal' growth hormone levels.West J Med. 1985 Jan;142(1):95-7. West J Med. 1985. PMID: 3976225 Free PMC article. No abstract available.
-
Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.J Endocrinol Invest. 1992 Mar;15(3):167-71. doi: 10.1007/BF03348697. J Endocrinol Invest. 1992. PMID: 1624675
MeSH terms
Substances
LinkOut - more resources
Full Text Sources